Literature DB >> 4045627

A new ambulatory system for extended esophageal pH monitoring.

L J Newman, S Berezin, J A San Filippo, M Halata, M S Medow, S M Schwarz.   

Abstract

A new 24-h ambulatory esophageal pH monitoring system (AMBI 24) was evaluated in 72 pediatric patients with suspected gastroesophageal reflux (GER). Forty-seven of these patients were monitored at home and the other 25 in our hospital. This system was employed without complication in infants and a full range of pediatric patients, as well as in older children with severe psychomotor delay. The data obtained were consistent with those reported utilizing standard monitoring equipment, and the results served as the basis for subsequent medical management. The results of this study, therefore, suggest that this method of esophageal pH monitoring is a safe and effective means of evaluating GER while allowing for patient mobility.

Entities:  

Mesh:

Year:  1985        PMID: 4045627     DOI: 10.1097/00005176-198510000-00004

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

Review 1.  Reflux vomiting.

Authors:  P J Milla
Journal:  Arch Dis Child       Date:  1990-09       Impact factor: 3.791

2.  Bronchial asthma and acid reflux into the distal and proximal oesophagus.

Authors:  P M Gustafsson; N I Kjellman; L Tibbling
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

3.  Diagnostic modalities for gastroesophageal reflux.

Authors:  A K Patwari; Pramila Bajaj; Ravi Kashyp; V K Anand; Ashutosh Gangil; Amit Jain; Gaurav Kapoor
Journal:  Indian J Pediatr       Date:  2002-02       Impact factor: 1.967

4.  Gastro-oesophageal reflux in infants. Evaluation of treatment by pH monitoring.

Authors:  Y Vandenplas; L Sacré-Smits
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

5.  Chest pain of gastrointestinal origin.

Authors:  S Berezin; M S Medow; M S Glassman; L J Newman
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.